• 9/19/25

Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization

Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories

Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies

You Might Also Like

Related Video Item Thumbnail Case Studies in Rare Disease Commercialization: Lessons Learned
Related Video Item Thumbnail Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies
Related Video Item Thumbnail Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials
Related Video Item Thumbnail Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter
Related Video Item Thumbnail Operationalizing Precision Medicine in Rare Disease Trials